In myasthenia gravis, surgical removal of the thymus gland proves to be effective and economical

In patients with myasthenia gravis, the surgical removal of the thymus gland, called thymectomy, added "quality adjusted life years" to patients and was also cost-effective in comparison to pharmacological treatment alone, according to a study published April 13 in JAMA Network Open. "Quality adjusted life years" are a measure used in health economics to represent how much a drug or intervention extends and improves one's quality of life.